List of Tables
Table 1. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Endocrine Therapy Drugs (ETDs) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) of Key Manufacturers (2019-2024)
Table 5. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Endocrine Therapy Drugs (ETDs) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Endocrine Therapy Drugs (ETDs) Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Endocrine Therapy Drugs (ETDs), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Product Type & Application
Table 12. Global Key Manufacturers of Endocrine Therapy Drugs (ETDs), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endocrine Therapy Drugs (ETDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Therapy Drugs (ETDs) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Endocrine Therapy Drugs (ETDs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2019-2024) & (Kiloton)
Table 18. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2019-2024)
Table 19. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2025-2030) & (Kiloton)
Table 20. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2025-2030)
Table 21. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2019-2024)
Table 23. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2025-2030)
Table 25. North America Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)
Table 27. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)
Table 28. North America Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)
Table 32. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)
Table 33. Europe Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Region (2019-2024) & (Kiloton)
Table 37. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Region (2025-2030) & (Kiloton)
Table 38. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)
Table 42. Latin America Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)
Table 43. Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2019-2024) & (Kiloton)
Table 47. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2025-2030) & (Kiloton)
Table 48. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Type (2019-2024)
Table 51. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Type (2025-2030)
Table 52. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2019-2024)
Table 53. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2025-2030)
Table 54. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2019-2024)
Table 57. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2025-2030)
Table 58. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Type (2019-2024)
Table 59. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Type (2025-2030)
Table 60. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Application (2019-2024)
Table 61. Global Endocrine Therapy Drugs (ETDs) Sales (Kiloton) by Application (2025-2030)
Table 62. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2019-2024)
Table 63. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2025-2030)
Table 64. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Endocrine Therapy Drugs (ETDs) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2019-2024)
Table 67. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2025-2030)
Table 68. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Application (2019-2024)
Table 69. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. AstraZeneca Endocrine Therapy Drugs (ETDs) Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Generex Biotechnology Corporation Information
Table 81. Generex Biotechnology Description and Business Overview
Table 82. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product
Table 84. Generex Biotechnology Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Sanofi Endocrine Therapy Drugs (ETDs) Product
Table 89. Sanofi Recent Developments/Updates
Table 90. MSD Corporation Information
Table 91. MSD Description and Business Overview
Table 92. MSD Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. MSD Endocrine Therapy Drugs (ETDs) Product
Table 94. MSD Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Pfizer Endocrine Therapy Drugs (ETDs) Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Huadong Medicine Corporation Information
Table 101. Huadong Medicine Description and Business Overview
Table 102. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product
Table 104. Huadong Medicine Recent Developments/Updates
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Bayer Endocrine Therapy Drugs (ETDs) Product
Table 109. Bayer Recent Developments/Updates
Table 110. Tonghua Dongbao Pharmaceutical Corporation Information
Table 111. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 112. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product
Table 114. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Endocrine Therapy Drugs (ETDs) Distributors List
Table 118. Endocrine Therapy Drugs (ETDs) Customers List
Table 119. Endocrine Therapy Drugs (ETDs) Market Trends
Table 120. Endocrine Therapy Drugs (ETDs) Market Drivers
Table 121. Endocrine Therapy Drugs (ETDs) Market Challenges
Table 122. Endocrine Therapy Drugs (ETDs) Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Endocrine Therapy Drugs (ETDs)
Figure 2. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Endocrine Therapy Drugs (ETDs) Market Share by Type in 2023 & 2030
Figure 4. Antidiabetic Drugs Product Picture
Figure 5. Anti-osteoporosis Drugs Product Picture
Figure 6. Contraceptive Product Picture
Figure 7. Other Product Picture
Figure 8. Global Endocrine Therapy Drugs (ETDs) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Endocrine Therapy Drugs (ETDs) Market Share by Application in 2023 & 2030
Figure 10. Diabetes Treatment
Figure 11. Osteoporosis Treatment
Figure 12. Contraception
Figure 13. Other
Figure 14. Global Endocrine Therapy Drugs (ETDs) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Endocrine Therapy Drugs (ETDs) Market Size (2019-2030) & (US$ Million)
Figure 16. Global Endocrine Therapy Drugs (ETDs) Sales (2019-2030) & (Kiloton)
Figure 17. Global Endocrine Therapy Drugs (ETDs) Average Price (US$/Ton) & (2019-2030)
Figure 18. Endocrine Therapy Drugs (ETDs) Report Years Considered
Figure 19. Endocrine Therapy Drugs (ETDs) Sales Share by Manufacturers in 2023
Figure 20. Global Endocrine Therapy Drugs (ETDs) Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Endocrine Therapy Drugs (ETDs) Players: Market Share by Revenue in 2023
Figure 22. Endocrine Therapy Drugs (ETDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Endocrine Therapy Drugs (ETDs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)
Figure 25. North America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)
Figure 26. United States Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)
Figure 29. Europe Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)
Figure 30. Germany Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2019-2030)
Figure 37. China Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)
Figure 47. Latin America Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Endocrine Therapy Drugs (ETDs) Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Endocrine Therapy Drugs (ETDs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Endocrine Therapy Drugs (ETDs) by Type (2019-2030)
Figure 57. Global Revenue Market Share of Endocrine Therapy Drugs (ETDs) by Type (2019-2030)
Figure 58. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Type (2019-2030)
Figure 59. Global Sales Market Share of Endocrine Therapy Drugs (ETDs) by Application (2019-2030)
Figure 60. Global Revenue Market Share of Endocrine Therapy Drugs (ETDs) by Application (2019-2030)
Figure 61. Global Endocrine Therapy Drugs (ETDs) Price (US$/Ton) by Application (2019-2030)
Figure 62. Endocrine Therapy Drugs (ETDs) Value Chain
Figure 63. Endocrine Therapy Drugs (ETDs) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed